Machado, P. M., Barohn, R. J., McDermott, M. P., Sundgreen, C., Blaettler, T., Hanna, M. G., & Dimachkie, M. (2024). Design and rationale for a randomized, double-blind, placebo-controlled Phase 2/3 trial of oral arimoclomol in inclusion body myositis. RRNMF Neuromuscular Journal, 5(2). https://doi.org/10.17161/rrnmf.v4i5.16244